Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib.

Graziani G, Artuso S, De Luca A, Muzi A, Rotili D, Scimeca M, Atzori MG, Ceci C, Mai A, Leonetti C, Levati L, Bonanno E, Tentori L, Caccuri AM.

Biochem Pharmacol. 2015 May 1;95(1):16-27. doi: 10.1016/j.bcp.2015.03.004. Epub 2015 Mar 17.

PMID:
25795251
2.

Mutations of human DNA topoisomerase I at poly(ADP-ribose) binding sites: modulation of camptothecin activity by ADP-ribose polymers.

Tesauro C, Graziani G, Arnò B, Zuccaro L, Muzi A, D'Annessa I, Santori E, Tentori L, Leonetti C, Fiorani P, Desideri A.

J Exp Clin Cancer Res. 2014 Sep 17;33:71. doi: 10.1186/s13046-014-0071-z.

3.

Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide.

Tentori L, Ricci-Vitiani L, Muzi A, Ciccarone F, Pelacchi F, Calabrese R, Runci D, Pallini R, Caiafa P, Graziani G.

BMC Cancer. 2014 Mar 5;14:151. doi: 10.1186/1471-2407-14-151.

4.

PARP-1 modulates amyloid beta peptide-induced neuronal damage.

Martire S, Fuso A, Rotili D, Tempera I, Giordano C, De Zottis I, Muzi A, Vernole P, Graziani G, Lococo E, Faraldi M, Maras B, Scarpa S, Mosca L, d'Erme M.

PLoS One. 2013 Sep 24;8(9):e72169. doi: 10.1371/journal.pone.0072169. eCollection 2013.

5.

Glucocorticoid-induced tumor necrosis factor receptor family-related ligand triggering upregulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 and promotes leukocyte adhesion.

Lacal PM, Petrillo MG, Ruffini F, Muzi A, Bianchini R, Ronchetti S, Migliorati G, Riccardi C, Graziani G, Nocentini G.

J Pharmacol Exp Ther. 2013 Oct;347(1):164-72. doi: 10.1124/jpet.113.207605. Epub 2013 Jul 26.

PMID:
23892569
6.

Epilepsy and brain injury: a case report of a dramatic neuropsychiatric vicious circle.

Rapinesi C, Del Casale A, Serata D, Kotzalidis GD, Scatena P, Muzi A, Lazanio S, Savoja V, Carbonetti P, Fensore C, Ferracuti S, Angeletti G, Tatarelli R, Girardi P.

Brain Inj. 2013;27(7-8):940-3. doi: 10.3109/02699052.2013.775489. Epub 2013 Jun 19.

PMID:
23782232
7.

Influence of MLH1 on colon cancer sensitivity to poly(ADP-ribose) polymerase inhibitor combined with irinotecan.

Tentori L, Leonetti C, Muzi A, Dorio AS, Porru M, Dolci S, Campolo F, Vernole P, Lacal PM, Praz F, Graziani G.

Int J Oncol. 2013 Jul;43(1):210-8. doi: 10.3892/ijo.2013.1932. Epub 2013 May 8.

PMID:
23653048
8.

MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination.

Tentori L, Muzi A, Dorio AS, Dolci S, Campolo F, Vernole P, Lacal PM, Praz F, Graziani G.

Cancer Chemother Pharmacol. 2013 Jul;72(1):117-25. doi: 10.1007/s00280-013-2175-0. Epub 2013 May 1.

PMID:
23636450
9.

NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug.

Caporali S, Levati L, Graziani G, Muzi A, Atzori MG, Bonmassar E, Palmieri G, Ascierto PA, D'Atri S.

J Transl Med. 2012 Dec 21;10:252. doi: 10.1186/1479-5876-10-252.

10.

Common fragile sites in colon cancer cell lines: role of mismatch repair, RAD51 and poly(ADP-ribose) polymerase-1.

Vernole P, Muzi A, Volpi A, Terrinoni A, Dorio AS, Tentori L, Shah GM, Graziani G.

Mutat Res. 2011 Jul 1;712(1-2):40-8. doi: 10.1016/j.mrfmmm.2011.03.006. Epub 2011 May 5.

PMID:
21570414
11.

The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma.

Tentori L, Dorio AS, Mazzon E, Muzi A, Sau A, Cuzzocrea S, Vernole P, Federici G, Caccuri AM, Graziani G.

Eur J Cancer. 2011 May;47(8):1219-30. doi: 10.1016/j.ejca.2010.12.008. Epub 2011 Jan 25.

PMID:
21269821
12.

Placenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-κB.

Levati L, Ruffini F, Muzi A, Umezawa K, Graziani G, D'Atri S, Lacal PM.

Int J Oncol. 2011 Jan;38(1):241-7.

PMID:
21109946
13.

Poly(ADP-ribose) polymerase signaling of topoisomerase 1-dependent DNA damage in carcinoma cells.

D'Onofrio G, Tramontano F, Dorio AS, Muzi A, Maselli V, Fulgione D, Graziani G, Malanga M, Quesada P.

Biochem Pharmacol. 2011 Jan 15;81(2):194-202. doi: 10.1016/j.bcp.2010.09.019. Epub 2010 Sep 25.

PMID:
20875401
14.

Pharmacological inhibition of poly(ADP-ribose) polymerase (PARP) activity in PARP-1 silenced tumour cells increases chemosensitivity to temozolomide and to a N3-adenine selective methylating agent.

Tentori L, Muzi A, Dorio AS, Scarsella M, Leonetti C, Shah GM, Xu W, Camaioni E, Gold B, Pellicciari R, Dantzer F, Zhang J, Graziani G.

Curr Cancer Drug Targets. 2010 Jun;10(4):368-83.

PMID:
20464779
15.

Evidence of the crucial role of the linker domain on the catalytic activity of human topoisomerase I by experimental and simulative characterization of the Lys681Ala mutant.

Fiorani P, Tesauro C, Mancini G, Chillemi G, D'Annessa I, Graziani G, Tentori L, Muzi A, Desideri A.

Nucleic Acids Res. 2009 Nov;37(20):6849-58. doi: 10.1093/nar/gkp669. Epub 2009 Sep 18.

16.

[Intestinal reconstruction after dehiscence of a jejunal suture in a patient submitted to aorto-enteric fistula repair: a case report].

Castriconi M, Muzi A, Bartone G, Maglio MN, Giuliano ME, Severino BU, Renda F.

Chir Ital. 2009 Mar-Apr;61(2):249-54. Italian.

PMID:
19537002
17.

Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells.

Vernole P, Muzi A, Volpi A, Dorio AS, Terrinoni A, Shah GM, Graziani G.

Mutat Res. 2009 May 12;664(1-2):39-47. doi: 10.1016/j.mrfmmm.2009.02.005. Epub 2009 Feb 21.

PMID:
19428379
18.

Pharmacological inhibition of poly(ADP-ribose) polymerase activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells.

Lacal PM, Tentori L, Muzi A, Ruffini F, Dorio AS, Xu W, Arcelli D, Zhang J, Graziani G.

Int J Oncol. 2009 Mar;34(3):861-72.

PMID:
19212692
19.

Valproic acid activity in androgen-sensitive and -insensitive human prostate cancer cells.

Iacopino F, Urbano R, Graziani G, Muzi A, Navarra P, Sica G.

Int J Oncol. 2008 Jun;32(6):1293-303.

PMID:
18497991
20.

Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity.

Tentori L, Muzi A, Dorio AS, Bultrini S, Mazzon E, Lacal PM, Shah GM, Zhang J, Navarra P, Nocentini G, Cuzzocrea S, Graziani G.

Eur J Cancer. 2008 Jun;44(9):1302-14. doi: 10.1016/j.ejca.2008.03.019. Epub 2008 Apr 24.

PMID:
18440222
21.

The integrin antagonist cilengitide increases the antitumor activity of temozolomide against malignant melanoma.

Tentori L, Dorio AS, Muzi A, Lacal PM, Ruffini F, Navarra P, Graziani G.

Oncol Rep. 2008 Apr;19(4):1039-43.

PMID:
18357394
22.

Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis.

Tentori L, Lacal PM, Muzi A, Dorio AS, Leonetti C, Scarsella M, Ruffini F, Xu W, Min W, Stoppacciaro A, Colarossi C, Wang ZQ, Zhang J, Graziani G.

Eur J Cancer. 2007 Sep;43(14):2124-33. Epub 2007 Aug 21.

PMID:
17714938
23.

Evidence that corticotropin-releasing hormone inhibits cell growth of human breast cancer cells via the activation of CRH-R1 receptor subtype.

Graziani G, Tentori L, Muzi A, Vergati M, Tringali G, Pozzoli G, Navarra P.

Mol Cell Endocrinol. 2007 Jan 29;264(1-2):44-9. Epub 2006 Nov 9.

PMID:
17097220
24.

Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma.

Tentori L, Leonetti C, Scarsella M, Muzi A, Mazzon E, Vergati M, Forini O, Lapidus R, Xu W, Dorio AS, Zhang J, Cuzzocrea S, Graziani G.

FASEB J. 2006 Aug;20(10):1709-11. Epub 2006 Jun 29.

PMID:
16809434
25.

Corticotropin-releasing hormone receptor-1 in human endometrial cancer.

Graziani G, Ferrandina G, Pozzoli G, Vergati M, Muzi A, Legge F, Tentori L, Scambia G, Navarra P.

Oncol Rep. 2006 Feb;15(2):375-9.

PMID:
16391857
26.

Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide.

Tentori L, Leonetti C, Scarsella M, Muzi A, Vergati M, Forini O, Lacal PM, Ruffini F, Gold B, Li W, Zhang J, Graziani G.

Eur J Cancer. 2005 Dec;41(18):2948-57. Epub 2005 Nov 8.

PMID:
16288862
27.

Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs.

Tentori L, Vergati M, Muzi A, Levati L, Ruffini F, Forini O, Vernole P, Lacal PM, Graziani G.

Int J Oncol. 2005 Aug;27(2):525-35.

PMID:
16010436
28.

N3-methyladenine induces early poly(ADP-ribosylation), reduction of nuclear factor-kappa B DNA binding ability, and nuclear up-regulation of telomerase activity.

Tentori L, Forini O, Fossile E, Muzi A, Vergati M, Portarena I, Amici C, Gold B, Graziani G.

Mol Pharmacol. 2005 Feb;67(2):572-81. Epub 2004 Nov 17.

PMID:
15548765
29.

[Use of the Cragg stent in the treatment of popliteal artery aneurysm: report of a case].

Maglione F, Spena M, Cavaglià E, Taliercio G, Minieri F, Muzi A.

Radiol Med. 1996 Nov;92(5):662-4. Italian. No abstract available.

PMID:
9036471
30.

Transient ischaemia refractory to conventional medical treatment in unstable angina: angiographic correlates and prognostic implications.

Pozzati A, Bugiardini R, Borghi A, Ottani F, Muzi A, Morgagni G, Puddu P.

Eur Heart J. 1992 Mar;13(3):360-5.

PMID:
1597223
31.

Angiographic morphology in unstable angina and its relation to transient myocardial ischemia and hospital outcome.

Bugiardini R, Pozzati A, Borghi A, Morgagni GL, Ottani F, Muzi A, Puddu P.

Am J Cardiol. 1991 Mar 1;67(6):460-4.

PMID:
1998276

Supplemental Content

Support Center